Developed by Glaukos, the iDose TR (travoprost intraocular implant) 75 mcg is a new, FDA-approved treatment that is designed ...

Ophthalmologists discuss how advanced imaging, MIGS, and home monitoring are reshaping decision-making in complex glaucoma ...

Glaucoma remains one of the leading causes of blindness in the United States, often progressing silently until vision loss has already occurred. Known as the “silent thief of sight,” the disease ...

As we age, our vision undergoes natural changes, including difficulty focusing on near objects (presbyopia) and reduced light ...

It's one of the most common causes of vision loss, and one of the easiest to overlook. Glaucoma symptoms develop so gradually ...

Glaucoma creeps in without pain or obvious symptoms, slowly damaging your optic nerve. Regular eye exams and early detection ...

Annual event accelerates progress toward curing glaucoma, from groundbreaking research to emerging therapiesSAN FRANCISCO, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Glaucoma Research Foundation (GRF) today ...

Synthetic cannabinoids and nicotinamide were among alternative treatment approaches discussed by Professor Augusto ...

There's fresh hope for early detection and new treatments of glaucoma, a group of eye diseases that have devastating effects ...

BOZEMAN, MT – November 04, 2025 – PRESSADVANTAGE – Glaucoma continues to be one of the most significant causes of vision loss across the country, often developing slowly and without obvious warning ...

"OMNI continues to deliver results for patients, whether it be patients undergoing cataract surgery, those that have already had cataract surgery and are now pseudophakic, or groups at historically ...